Reproductive Medicine Associates of CT | Fertility Centers of Excellence – CT & NY

800.865.5431
  • Newsletter

    Sign up for RMACT News & Events

    Privacy Policy

  • Testimonials

    Patient Testimonials

    RMACT doctors & staff were friendly, straightforward, helpful and ethical. The staff involved us in every decision and we always had final say.

    Greenwich, CT

  • Connect with RMACT

    Connect with RMACT:

  • Billing Questions?

    Billing
    Questions?

    Click Here >
  • Assisted Reproductive Technology (ART) Research

  • Social Icons

    es
  • 24-Chromosome Aneuploidy Screening

    In collaboration with our Reproductive Medicine Associates affiliate clinic, a recent cutting-edge clinical study was conducted involving technology known as 24-Chromosome Aneuploidy Screening.  It is expected that this form of preimplantation genetic diagnosis (PGD) can be used to more accurately detect healthy embryos for implantation, leading to more successful pregnancies and healthy babies.

    The procedure starts when a couple begins IVF treatment. Several days after their embryo is created by combining harvested eggs and sperm, all 24 pairs of chromosomes are present and a biopsy of the embryo is performed. Computer analysis is used to identify any abnormalities among the chromosomes – including genetic diseases and– before the embryo is implanted in the woman’s uterus.

    What distinguishes 24-Chromosome Aneuploidy Screening from other PGD processes is that the embryo is able to grow for up to five days, allowing the cells to split and the chromosomal analysis to be more accurate. In fact, 24-Chromosome Aneuploidy Screening works more quickly while the embryo is at its key stage for analysis and has more accurate results than the previously dominant PGD treatment known as FISH (Florescent in-situ Hybridization).

    In addition to detecting specific conditions, this advanced embryo selection technique dramatically reduces miscarriage rates and reduces the need to implant multiple embryos to achieve conception.

    Dr. Mark P. Leondires, Medical Director of RMACT and lead physician for RMACT on the clinical study, believes this new technology is an important step toward healthy pregnancies. “Through our advancements, we can identify the best embryos for a healthy pregnancy,” he says. “We can also offer our patients who have had several miscarriages closure because they can know the cause of these miscarriages, and make decisions about how to move forward with their fertility treatment.”

  • Schedule an Appointment

    Schedule an Appointment

    Fertility Doctors CT | NY. Schedule Appointment
  • View our Impressive Pregnancy Rates

  • Join the RMACT Conversation.Read our Blog

  • Learn About Fertility Treatment Options.

    Learn About Fertility Treatment Options.

    Read More Fertility Treatment in CT | Connecticut | NY
  • Financing Your Fertility Treatment

  • RMACT Fertility Clinics Provide Fertility Testing, Diagnosis & Treatment in CT & NY:

    Affiliates

    Copyright Footer English

    Call 1-800-865-5431 to Schedule an Appointment

    Copyright © 2013 RMA of Connecticut.
    All Rights Reserved.

    Privacy Policy | Terms of Use

    Verify Here
    es